Köhrer, S
Havranek, O
Seyfried, F
Hurtz, C
Coffey, G P
Kim, E
ten Hacken, E
Jäger, U
Vanura, K
O'Brien, S
Thomas, D A
Kantarjian, H
Ghosh, D
Wang, Z
Zhang, M
Ma, W
Jumaa, H
Debatin, K-M
Müschen, M
Meyer, L H
Davis, R E
Burger, J A
Article History
Received: 21 August 2015
Revised: 20 November 2015
Accepted: 23 December 2015
First Online: 5 February 2016
Competing interests
: JAB received research funding from Portola Pharmaceuticals and GPC is employee and shareholder of Portola Pharmaceuticals.